Medical Xpress August 20, 2024
The saga of cancer treatment is marked by a relentless pursuit of effectiveness against a disease characterized by complexity and adaptability. While immunotherapy has opened new frontiers, the challenges posed by tumor diversity and immune evasion call for innovative solutions. The drive to achieve precision in targeting cancer’s Achilles heel without harming healthy tissue is propelling the exploration of neoantigen vaccines.
The Cell Biotechnology Laboratory and Department of Thoracic Oncology at Tianjin Cancer Hospital Airport Hospital, in synergy with the National Clinical Research Center for Cancer and Haihe Laboratory of Synthetic Biology, has conducted a review of neoantigen cancer vaccines.
Published in Cancer Biology & Medicine, the work promises to illuminate the path forward in cancer immunotherapy with a spotlight...
Today's Sponsors
Today's Sponsor